CRNX
Price
$35.61
Change
+$1.36 (+3.97%)
Updated
Sep 5 closing price
Capitalization
3.23B
61 days until earnings call
TRML
Price
$26.74
Change
+$1.64 (+6.53%)
Updated
Sep 5 closing price
Capitalization
687.01M
Interact to see
Advertisement

CRNX vs TRML

Header iconCRNX vs TRML Comparison
Open Charts CRNX vs TRMLBanner chart's image
Crinetics Pharmaceuticals
Price$35.61
Change+$1.36 (+3.97%)
Volume$1.42M
Capitalization3.23B
Tourmaline Bio
Price$26.74
Change+$1.64 (+6.53%)
Volume$447.78K
Capitalization687.01M
CRNX vs TRML Comparison Chart in %
Loading...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRNX vs. TRML commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRNX is a StrongBuy and TRML is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (CRNX: $35.61 vs. TRML: $26.74)
Brand notoriety: CRNX and TRML are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRNX: 149% vs. TRML: 260%
Market capitalization -- CRNX: $3.23B vs. TRML: $687.01M
CRNX [@Biotechnology] is valued at $3.23B. TRML’s [@Biotechnology] market capitalization is $687.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRNX’s FA Score shows that 0 FA rating(s) are green whileTRML’s FA Score has 1 green FA rating(s).

  • CRNX’s FA Score: 0 green, 5 red.
  • TRML’s FA Score: 1 green, 4 red.
According to our system of comparison, TRML is a better buy in the long-term than CRNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRNX’s TA Score shows that 5 TA indicator(s) are bullish while TRML’s TA Score has 5 bullish TA indicator(s).

  • CRNX’s TA Score: 5 bullish, 5 bearish.
  • TRML’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, TRML is a better buy in the short-term than CRNX.

Price Growth

CRNX (@Biotechnology) experienced а +14.91% price change this week, while TRML (@Biotechnology) price change was +14.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Reported Earning Dates

CRNX is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRNX($3.23B) has a higher market cap than TRML($687M). TRML YTD gains are higher at: 31.854 vs. CRNX (-30.354). TRML has higher annual earnings (EBITDA): -102.41M vs. CRNX (-419.62M). CRNX has more cash in the bank: 1.2B vs. TRML (239M). TRML has less debt than CRNX: TRML (145K) vs CRNX (49.9M). CRNX has higher revenues than TRML: CRNX (1.39M) vs TRML (0).
CRNXTRMLCRNX / TRML
Capitalization3.23B687M470%
EBITDA-419.62M-102.41M410%
Gain YTD-30.35431.854-95%
P/E RatioN/AN/A-
Revenue1.39M0-
Total Cash1.2B239M500%
Total Debt49.9M145K34,414%
FUNDAMENTALS RATINGS
CRNX: Fundamental Ratings
CRNX
OUTLOOK RATING
1..100
13
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
PROFIT vs RISK RATING
1..100
64
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
53
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRNXTRML
RSI
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
82%
Momentum
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
85%
Declines
ODDS (%)
Bearish Trend 18 days ago
77%
Bearish Trend 30 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
82%
Aroon
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OEPSX59.66N/A
N/A
Oil Equipment&Svcs UltraSector Pro Svc
DLQIX16.56N/A
N/A
BNY Mellon Large Cap Equity I
GROYX62.86N/A
N/A
Victory Pioneer Select Mid Cap Growth Y
FHKFX10.67N/A
N/A
Fidelity Series Emerging Markets
RPPRX31.68N/A
N/A
Victory RS Partners R6

CRNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with XNCR. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
+3.97%
XNCR - CRNX
63%
Loosely correlated
+2.15%
RVMD - CRNX
58%
Loosely correlated
+3.98%
IDYA - CRNX
57%
Loosely correlated
+5.15%
NRIX - CRNX
56%
Loosely correlated
+8.66%
SYRE - CRNX
56%
Loosely correlated
+0.06%
More

TRML and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRML has been closely correlated with SPHDF. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if TRML jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRML
1D Price
Change %
TRML100%
+6.53%
SPHDF - TRML
78%
Closely correlated
N/A
CRNX - TRML
43%
Loosely correlated
+3.97%
IMNM - TRML
43%
Loosely correlated
+7.35%
STOK - TRML
43%
Loosely correlated
+5.35%
SYRE - TRML
41%
Loosely correlated
+0.06%
More